Pfizer says FDA has approved its migraine nasal spray Zavzpret
Drugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Drugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.